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age of the patients was 55.95 yrs, of which 89.58 %weremales. The
average weight was 72.67 kg. The indications for PCI were 46.18 %
Unstable angina, 20.72% NSTEMI and 33.10% STEMI. 86.92% pa-
tients took a loading dose of 60 mgs whereas 13.08% patients who
had taken loading dose of clopidogrel were given only mainte-
nance dose of 10 mgs/day. A total of 26 adverse events were
noticed. Preliminary analysis revealed death of 2 patients due to
possible stent thrombosis. Three patients required revasculari-
zation (1 for stent thrombosis & 2 others for a different vessel
intervention) and 1 required rehospitalisation however for a non
cardiac cause. Major bleeding was seen in 1 patient whereas 19
patients experienced minor bleeds.
Comparison of clopidogrel vs prasugrel in patients
going for PCI-2 year follow-up
K.A. Sambasivam, S. Natarajan, P.R. Vydianathan,
Rajpal K. Abaichand, P.I.S. Chakravarthi, J.K. Periyaswamy,
Bivin Wilson, S. Suvasini, M. Ramya
G. Kuppuswamy Naidu Memorial Hospital, Coimbatore, India
Background: There has been no Indian data on the efficacy and
safety of prasugrel VS clopidogrel.
Aim: To compare the efficacy and safety of prasugrel with that of
clopidogrel in patients who underwent PCI.
Methods: This is a retrospective observational study. We collected
the data from patients who underwent elective/emergency PCI and
were given prasugrel and clopidogrel. The studywas between 2010-
2012. 235 patients formed the cohort. Group I consisted of 129 pa-
tients who were treated with clopidogrel and group II was of 106
patients treated with clopidogrel. Prasugrel group received loading
doseof (LD)60mg followedbymaintenancedose (MD)of 10mgonce
daily. LD and MD of clopidogrel was variable. We collected and
analysed the baseline characteristics and in hospital , 30 days, 6
months, 18 months and 24 months major adverse vascular events.
Primary end point was composite of death, ACS, stroke, emergency
revascularisation, stent thrombosis, major bleeding. Individual
secondary end points considered were admission for CCF, stent
thrombosis, instent restenosis, minor bleed, hospital stay and ACS.
Results: Mean age and sex distribution were similar in both the
groups. Dyslipidemia, hypertension, family history, two vessel
disease were higher in group II. More patients in group II had past
history of MI, prior PCI and CABG .STEMI numbers were high in
group I. Group I had significantly more primary PCI and use of GP
IIB III a blocker . In hospital complications were comparable in
both the groups. There was no significant difference between the
groups in the composite primary end points during the entire
follow up period. ACS was the only secondary endpoint that
occurred significantly in group 2 (p 0.03).
Conclusion: The efficacy and safety of prasugrel was comparable
to that of clopidogrel in our study. Occurrence of ACS was
significantly more in prasugrel group.
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Background: Acute Coronary syndrome in very young adults
(<35yrs) was considered as an uncommon entity, recently shows
rising incidence especially in India. ACS in this younger age is not,
simply a problem of sufferers but a huge emotional and
economical loss to the family.
Materials and Methods: This is a prospective analytical study
included patient <35yrs with ACS admitted in GovtRajajihospital
(Madurai Medical College) in TamilNadu during Jan2013 to June
2014. Risk factors, clinical, angiographic profile and follow up data
were recorded and analyzed.
Results: Among the total 2180 patients with ACS, 5.8 % (n¼127)
were very young adults. Youngest one was 11 yrs old with coro-
nary anomaly. Mean age was 29.7yrs (±3.7) and only 8.6% (n¼10)
were obese. Patients reached the hospital with median delay of
7hrs.Smoking (85%), male sex (93.9%) were the major conven-
tional risk factors followed by low HDL (52%). Family history of
premature coronary event seen in 12.9%, hyperhomocysteinemia,
elevated Lpa and high fibrinogen were observed in 15%, 20% &
3.5% respectively. Anteriorwall MI with LAD occlusion was the
commonest type (66.3%). Only 2 were undergone primary PCI
(1.7%), 61% (n¼71) received thrombolytic therapy. Median delay
for angiogram was 72hrs (3 days). Angiographically majority
(53.4%) had SVD, 31% had recanalised vessels. Coronary anomaly
was seen in 4 (3.4%) patients and pure ectasia in 3 (2.5%) patients.
Mean EF was 42% (±7). In hospital mortality was 3.4% and 4.5 %
(n¼5) during followup.
Conclusion: Our observation showed, obstructive CAD in 56.9% of
young ACS patients (<35yrs). This rapid progression of athero-
sclerosis in Indians is not simply due to conventional risk factors
alone but due to complex interaction of both conventional and
novel risk factors. Significant admission and therapeutic delay
implicate the need of active strategies to protect these budding
adults.
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Background: Treatment delay in the management of STEMI /
NSTEMI inversely correlates with prognosis and survival of the
patients. This study was aimed to investigate factors associated
with delay in the thrombolytic therapy of these patients in a
municipal teaching hospital.
Methods: Data was collected prospectively of all patients who
were admitted with acute myocardial infarction from March 2014
e June 2014. Old myocardial infarction / old coronary artery
bypass graft surgery/old percutaneous transluminal coronary
angioplasty (PTCA) patients were excluded. The cardiology regis-
trar in casualty initially filled the questionnaire and sent it to the
cardiology registrar in ICCU. The cardiology registrar on duty in
ICCU completed the questionnaire at discharge. The question-
naire comprised of age, gender, weight, address, presenting
symptoms, chest pain type, onset, events between chest pain
onset and presentation to hospital, time between symptom onset
and presentation to hospital, mode of transport to hospital, risk
factors- smoking/diabetes/hypertension/dyslipidemia /family
history , previous history of angina, socioeconomic status,
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